Medicalgorithmics: Q1 2024 Confirms Business Model and Strategy
In Q1 2024, Medicalgorithmics—a medtech company listed on the sWIG80 index—successfully focused on acquiring new customers. The company has established 9 new partnerships so far, including five in the USA. According to the strategy, new clients are expected to replace a former exclusive partner in the USA. Only three of the already commercially launched projects will bring the company about 440,000 PLN in average monthly recurring revenue, which is nearly 50% of the sales in Q4 2023 for the former client. Thus, the company is consistently transforming its business model. In the first quarter of 2024, its revenue amounted to 7 million PLN. The Medicalgorithmics Management expects significant sales growth in the coming quarters due to the commencement of services for new clients.